DBC vs IBB
Invesco DB Commodity Index Tracking Fund vs iShares Biotechnology ETF
DBC$27.58
Invesco DB Commodity Index Tracking Fund
Diversified commodity basket.
Expense: 0.85%Yield: 2.80%
IBB$197.34
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.22%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.85% for DBC.
- • DBC pays a higher dividend yield (2.80%).
Side-by-side metrics
| Metric | DBC | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.85% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.80% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $1.58B | $9.09B |
YTD return | 24.33% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.05 | 0.69 |
P/E ratio | 6.67 | 24.89 |
Last price | $27.58 | $197.34 |
Inception | — | — |
Issuer | Invesco | iShares |
DBC top holdings
Top holdings · DBC
| AGPXX | Invesco Shrt-Trm Inv Gov&Agcy Instl | 37.02% |
| BRNZ26 | Brent Crude Future Oct 26 | 7.56% |
| TBLL | Invesco Short Term Treasury ETF | 6.59% |
IBB top holdings
Top holdings · IBB
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
Sector breakdown · IBB
Healthcare100.0%
About DBC
DBC (Invesco DB Commodity Index Tracking Fund) is Diversified commodity basket. Managed by Invesco, the fund carries $1.6B in assets under management, an expense ratio of 0.85%, a dividend yield of 2.80%. Its largest holding is Invesco Shrt-Trm Inv Gov&Agcy Instl (AGPXX), which represents 37.0% of the portfolio.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.